跳至主要内容
临床试验/ISRCTN14907042
ISRCTN14907042已完成不适用

Evaluation of gabapentin as a pre-emptive analgesic for patients undergoing total hip arthroplasty

Sunnybrook Health Sciences Centre (Canada)0 个研究点目标入组 90 人开始时间: 2005年10月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Upon obtaining informed consent, patients with American Society of Anesthesiologists physical status I and II, of both genders, scheduled for hip arthroplasty will be recruited for this double-blinded, prospective, randomized, and placebo-controlled study. Patients must also be 18?70 years of age.

排除标准

  • 1. Patients not providing informed consent
  • 2. Patients less than 18 years of age and greater than 75 years of age
  • 3. Known allergy to any of the medications being used
  • 4. History of drug or alcohol abuse
  • 5. Patients with chronic pain on slow-release preparations of opioid
  • 6. Patients with rheumatoid arthritis
  • 7. Patients with psychiatric disorders
  • 8. Patients unable or unwilling to use patient-controlled analgesia
  • 9. Diabetic patients or those with impaired renal function (creatinine >106)
  • 10. Obese patients (i.e., body mass index [BMI] >40)

研究者

发起方
Sunnybrook Health Sciences Centre (Canada)

相似试验

Evaluation of gabapentin as a pre-emptive analgesic... | 临床试验